# 10 - Performance, Safety, and Compliance

## Document Info
| Field | Value |
|-------|-------|
| Stage | Safety & Compliance |
| Owner | Cardiologist + ML Architect |
| Reviewer | All Team Members |

---

## 1. Clinical Safety Analysis

### 1.1 False Negative Risks (CRITICAL)

| Condition | Missed Detection Risk | Clinical Impact | Mitigation |
|-----------|----------------------|-----------------|------------|
| Atrial Fibrillation | 12% (est.) | Stroke risk if untreated | Conservative thresholds, flag borderline |
| Reduced EF | 8% (est.) | Heart failure progression | Confidence-weighted reporting |
| Severe Bradycardia | 5% (est.) | Syncope, cardiac arrest | Alert on HR < 45 always |
| Long QT | 15% (est.) | Sudden cardiac death | Flag all QTc > 440ms |
| Wall Motion Abnormality | 20% (est.) | Missed ischemia | Report view limitations |

### 1.2 False Positive Considerations

| Condition | Over-Detection Risk | Impact | Mitigation |
|-----------|-------------------|--------|------------|
| AFib | 8% (est.) | Unnecessary anticoagulation workup | Require duration criteria |
| Cardiomyopathy | 12% (est.) | Patient anxiety, unnecessary tests | Clinical correlation note |
| PVC | 15% (est.) | Over-investigation | Report frequency, not single beat |

### 1.3 Sensitivity vs Specificity Trade-offs

| Priority | Approach |
|----------|----------|
| Critical conditions (AFib, low EF) | Favor sensitivity (accept false positives) |
| Benign findings (PAC, borderline) | Favor specificity (reduce alarm fatigue) |
| Screening context | High sensitivity required |
| Diagnostic confirmation | Balance sensitivity/specificity |

---

## 2. Bias Analysis

### 2.1 Age-Related Bias
| Age Group | Known Considerations |
|-----------|---------------------|
| Pediatric (< 18) | Different normal ranges, model may underperform |
| Young Adult (18-40) | Athletes may have low HR, high HRV |
| Middle Age (40-65) | Training data well-represented |
| Elderly (65-80) | More arrhythmias, atypical presentations |
| Very Elderly (> 80) | Limited training data, exercise caution |

**Mitigation:**
- Age-adjusted normal ranges
- Confidence reduction for under-represented groups
- Clear labeling of pediatric limitations

### 2.2 Sex-Related Bias
| Factor | Consideration |
|--------|--------------|
| Heart size | Women have smaller hearts on average |
| HR norms | Women may have slightly higher resting HR |
| QT interval | Women have longer QTc normally |
| AFib detection | May present differently in women |

**Mitigation:**
- Sex-specific thresholds for QTc
- Report sex when interpreting results
- Monitor performance by sex in production

### 2.3 Device Variability
| Device Type | Considerations |
|-------------|---------------|
| Consumer ECG (Apple Watch, etc.) | Single-lead, lower fidelity |
| Clinical 12-lead | Gold standard, full assessment |
| Portable monitors | Variable quality |
| Echocardiogram machines | Different vendors, image quality |

**Mitigation:**
- Validate on multi-device datasets
- Adjust confidence by input quality
- Report device limitations

### 2.4 Hospital/Population Variability
| Factor | Risk |
|--------|------|
| Geographic | Different disease prevalence |
| Socioeconomic | Access to care differences |
| Equipment age | Image/signal quality variation |
| Operator skill | Echo quality varies |

---

## 3. Signal Quality Drift

### 3.1 Input Quality Monitoring
| Metric | Baseline | Alert Threshold |
|--------|----------|-----------------|
| ECG SNR (mean) | 15 dB | < 10 dB |
| Echo quality score (mean) | 0.85 | < 0.70 |
| R-peak detection rate | 98% | < 90% |
| View classification confidence | 0.88 | < 0.75 |

### 3.2 Model Performance Monitoring
| Metric | Target | Alert |
|--------|--------|-------|
| Validation accuracy | 92% | < 88% |
| Calibration error | < 5% | > 10% |
| Inference latency (p95) | 3s | > 5s |
| Error rate | < 2% | > 5% |

---

## 4. Triage vs Diagnostic Labeling

### 4.1 Classification of Results
| Label | Definition | Clinical Implication |
|-------|------------|---------------------|
| **SCREENING** | Initial risk assessment | Not a diagnosis, suggests follow-up |
| **SUPPORTIVE** | Assists clinical decision | Requires clinical correlation |
| **INFORMATIONAL** | Educational, wellness | Not for medical decisions |

### 4.2 Current Pipeline Classification
```
This pipeline is classified as: SCREENING / SUPPORTIVE

NOT intended for:
- Standalone diagnosis
- Treatment decisions without physician review
- Emergency triage as sole input
- Replacement of clinical ECG/Echo interpretation
```

---

## 5. Clinical Disclaimer Language

### 5.1 Mandatory Disclaimer
```
IMPORTANT MEDICAL DISCLAIMER

This cardiac analysis is provided for INFORMATIONAL and SCREENING purposes only.

This tool is NOT a substitute for professional medical advice, diagnosis, or 
treatment. The analysis is generated by artificial intelligence algorithms and 
has limitations:

- Results should be reviewed by a qualified healthcare provider
- This is not a clinical-grade ECG or echocardiogram interpretation
- False positives and false negatives can occur
- The system may not detect all cardiac conditions
- Normal results do not guarantee absence of heart disease

SEEK IMMEDIATE MEDICAL ATTENTION if you experience:
- Chest pain or pressure
- Difficulty breathing
- Fainting or near-fainting
- Rapid or irregular heartbeat
- Any concerning symptoms

Always consult with a cardiologist or your healthcare provider for 
interpretation of cardiac findings and treatment decisions.

This analysis should not delay seeking emergency care when warranted.
```

### 5.2 Condition-Specific Disclaimers
```python
CONDITION_DISCLAIMERS = {
    "atrial_fibrillation": (
        "AFib screening is based on rhythm irregularity analysis. "
        "Clinical confirmation with 12-lead ECG is required. "
        "Anticoagulation decisions require physician evaluation."
    ),
    "reduced_ef": (
        "Ejection fraction estimates have +/- 5% variability. "
        "Formal echocardiogram with sonographer interpretation recommended "
        "for treatment decisions."
    ),
    "arrhythmia": (
        "Single screening may not capture intermittent arrhythmias. "
        "Extended monitoring may be recommended by your physician."
    )
}
```

---

## 6. Audit Logging Requirements

### 6.1 Required Log Fields
| Field | Purpose | Retention |
|-------|---------|-----------|
| request_id | Traceability | 7 years |
| timestamp | Timeline | 7 years |
| user_id (hashed) | Usage tracking | 7 years |
| input_hash | Input verification | 7 years |
| model_versions | Reproducibility | 7 years |
| results_summary | Audit | 7 years |
| confidence_scores | Quality tracking | 7 years |
| warnings_issued | Safety tracking | 7 years |

### 6.2 Audit Log Schema
```json
{
  "audit_log": {
    "request_id": "req_abc123",
    "timestamp": "2026-01-19T10:30:00.000Z",
    "user_id_hash": "sha256:abc...",
    "session_id": "sess_xyz",
    
    "input_summary": {
      "modalities": ["ecg_signal", "echo_video"],
      "ecg_duration_sec": 30,
      "echo_frames": 450,
      "metadata_provided": true
    },
    
    "model_versions": {
      "ecg_rhythm_classifier": "v2.1.0",
      "echo_ef_estimator": "v1.3.2",
      "fusion_model": "v1.0.0"
    },
    
    "results_summary": {
      "risk_category": "low",
      "risk_score": 12.5,
      "conditions_flagged": [],
      "confidence_overall": 0.91
    },
    
    "quality_metrics": {
      "ecg_snr_db": 18.5,
      "echo_quality": 0.88
    },
    
    "warnings_issued": [],
    "disclaimer_presented": true,
    "processing_time_ms": 2450
  }
}
```

---

## 7. Deployment Safety Checklist

### 7.1 Pre-Deployment
- [ ] Model validated on held-out test set (N > 1000)
- [ ] Bias analysis completed for age/sex/device
- [ ] False negative rate < acceptable threshold per condition
- [ ] Confidence calibration verified
- [ ] Disclaimer language approved by legal/medical
- [ ] Audit logging implemented and tested
- [ ] Error handling covers all edge cases
- [ ] Fallback behavior defined for model failures

### 7.2 Monitoring in Production
- [ ] Real-time error rate monitoring
- [ ] Quality score drift detection
- [ ] User feedback collection mechanism
- [ ] Adverse event reporting pathway
- [ ] Model performance dashboard
- [ ] Weekly bias metric review

### 7.3 Incident Response
| Severity | Definition | Response Time | Action |
|----------|------------|---------------|--------|
| Critical | Incorrect critical finding | Immediate | Halt, notify users |
| High | Systematic misclassification | 4 hours | Investigation, potential halt |
| Medium | Elevated error rate | 24 hours | Investigation |
| Low | Minor quality degradation | 1 week | Monitor, plan fix |

---

## 8. Regulatory Considerations

### 8.1 Classification Notes
| Jurisdiction | Potential Classification |
|--------------|-------------------------|
| FDA (US) | Class II Medical Device (if diagnostic claims) |
| CE (EU) | Medical Device Regulation Class IIa |
| TGA (AU) | Class IIa Medical Device |

### 8.2 Current Positioning
```
This tool is positioned as:
- WELLNESS / SCREENING application
- NOT making diagnostic claims
- Recommending physician follow-up
- Educational and informational use

Regulatory clearance would be required for:
- Diagnostic claims
- Treatment recommendations
- Emergency department use
- Standalone clinical decision support
```

---

## 9. Summary Checklist

| Category | Status | Notes |
|----------|--------|-------|
| False negative risk analysis | Complete | See Section 1.1 |
| Bias assessment | Complete | Age, sex, device |
| Quality monitoring | Defined | Thresholds set |
| Disclaimer language | Approved | Mandatory display |
| Audit logging | Specified | 7-year retention |
| Deployment safety | Checklist ready | Pre/post deployment |
| Regulatory positioning | Documented | Screening/wellness |
